pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-203b |
Genomic Coordinates | chr14: 104117418 - 104117503 |
Description | Homo sapiens miR-203b stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-203b-3p | |||||||||||||||
Sequence | 54| UUGAACUGUUAAGAACCACUGGA |76 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TANGO2 | ||||||||||||||||||||
Synonyms | C22orf25, MECRCN | ||||||||||||||||||||
Description | transport and golgi organization 2 homolog | ||||||||||||||||||||
Transcript | NM_152906 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TANGO2 | |||||||||||||||||||||
3'UTR of TANGO2 (miRNA target sites are highlighted) |
>TANGO2|NM_152906|3'UTR 1 CCCCACCTCTGGGCCTGGCCAGTGGGCTCCTGGGGGGCCCTGCCTTGAGGGGCACTGTGGACAGGAAACCTTCCTTTGCC 81 ATACTGCATTGCACTGCCCGTGGCTTGGCCAGCATCCCCCGGATCAGGGCCCTGTGGTTTGCGTGTTACCCATCTGTGTC 161 CCCATGCCCAGTTCAGGGTCTGCCTTTATGCCAGTGAGGAGCAGCAGAGTCTGATACTAGGTCTAGGACCGGCCGAGGTA 241 TACCATGAACATGTGGATACACCTGAGCCCACTCTTGCACATGTACACAGGCACTCACATGGCACACACATACACTCCTG 321 CGTGTGCACAAGCACACACATGCAAGCCATATACATGGACACCGACACAGGCACATGTACGTGCACAGGTGTGCTACACA 401 TGTGCACACATGCACAGTTGCACAGACACACACACACAGGTGCACACACACGATGCCGAACAAGGCAGAAGGGCGACTCT 481 CACCTCTCATGTGCTTCTGGCCAGTAGGTCTTTGTTCTGGTCCAACGACAGGAGTAGGCTTGTATTTAAAAGCGGCCCCT 561 CCTCTCCTGTGGCCACAGAACACAGGCGTGCTTGGACTCTTGACAAGCAGACCTGCTCCTGCAGAGGAGACAGCCACATT 641 TGGAATTGGGCACCGAGAAGACCTGAGAAAAACCCACTCTCTCTTTTTTTTTTTTTTGAGACGGAGTCTTGCTCTGTCAC 721 CCAGGCTGGAGTGCAGTGGCACGATCTCGGCTCACTGCAACCTCCGCCTCCCAAGTTCAAGCAATTCTCCTGCCCCAGCC 801 TCCTGATTAGCTGGGATTACAGGCGTGTGCCACCATGCCCAGCTAATTTTTGTGTTTTTAGTAGAGACGGGGTTTCACCA 881 TGTTGGTCAGGCTGGTCTTGAACTCCTGACGTGGTGATCCACCTGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTG 961 AGCCACCACGCCTGGCCGAAAAACCCACTCTCATAACAGAAGTGCAGACTCATTGCTAGATTCAGTGCCCTTGAGTGTGC 1041 CAGAGGTCCTCTGTGTTTGAGACAATCCTGTGTGTGCCAGGAGGCTCCGTGTGCACCAGGGGCTCTCAGAATCCCGCTTA 1121 CCCAGCTGGAGACCATGCCTCTGGCAGCCCCATCTCAGCCAGCCCTGCTCTCTCCCTCTTCCCTCCAGGTGAGGCAAACT 1201 TCATAGGAATCTGTACCTGAATGTGAGCTCCTGATAATAAAACTCTGAGGCTTTGGTGAGCGCATTTCGAGGCCTTTCCC 1281 TTGTATGCAGGGTGCCAGTGGGAGCTGCTATGTCTCCTGTGCAGCCAGACACCCTGGACGAGGCCCTTCCCACCTCCCCC 1361 TTTCCTCACGGCTTCTTCAGCACCACATGTGGATGCCTGTGGGTCAGTCCATCTGTCCATGGGCAGGGGCCGCTGTGAGA 1441 GACCCCATGCGCGTGGGATGTGGTAGATGCTGATTATGGGGCCAGCCACCCATACAGGTCTATCAGGTCGCAATGGAGGC 1521 CCCACTGGAGCGGGAGGCAGGCTGGCCTGGACTTCTGTTGGATGATGGGGGCCAGGGGATGGTAGGAGGGGCAGGAGAGC 1601 AGGTCTGCATCTGTCTCAGCCCCAGGAGCTCCTGGTTTGGGGCCAGCTCTAAGGAGCTTCATCCCTGAGCCTGGCCGAGT 1681 ATAAGGGGGTCCCGGATATCCAATGCTGAGACCTAGACTTTTCTAAGCCTCTGCACCCAACCCCTAACTTGGCCTTTTCA 1761 GACCCATGAGAGTGCAGGGTGGGTGTGGACCTGCGCCAGGGCTTCCCAGCCTGATTGTGACATGATGTGAGTCCACCTAG 1841 GGAGGAGCAGGGGCCTCCCCGTCTCTTCCCCTTCTTGCCCAGACCACTTTGCTGGGCTCAGAGCCTTCCATGGCTCACTT 1921 TGAACTCAGAAGAGTTTCCCAGCTGCGACCCAGGCTGCACCCCCAGGCCTGAGGAGAAACTGAGGCCCCACATCCCATAC 2001 GTGTCCTCTGAGTCAGGACAACAGGCTCCCGGCTGGGGGCACTGCCCTTGCTGCCAACACATTCACCTGCCCCAGTGGCT 2081 ACCATGTCCTGTGCCGGTGACCAGTGCCAGTCCCCAACCTGGATGGTGCCCTGCCCTCATGAAGAGCCCCCCGGATGTTC 2161 ACCTCTGCCCAGAGACCCGGCCTGCCCAGGAAGAGCAGTCTCTGCTCTTGTGTGGGTCCCTCTGCCCCCACCCTGCCCAG 2241 GGCTCCCCAGCAGCCTGAGGCCCCTAAGGAAGAACAGCCCTCAATGGTGATTCTATTGGTGTTATGAGTTGTGTCCCCAA 2321 AGAGATATATCAGTGTCCTGACCCACAGTACCTCAGAATGTGACTGCATTTGGAGATAGGGTTCTTCCAGGGGTAACCAA 2401 GGTAGAATGAGGTCGTTAGTGTGGGCCCTAATCCAATATGACGGCTATCCTTATAAAAAGAGGAACATTTAGGCTGGATA 2481 CAGTGGCTCATGCCTATAATCC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000434570.2 | 3UTR | CCUCCCAAGUUCAAGCAAUUCUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
154 hsa-miR-203b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT063500 | SKI | SKI proto-oncogene | 2 | 4 | ||||||||
MIRT149737 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT206557 | SOCS5 | suppressor of cytokine signaling 5 | 2 | 8 | ||||||||
MIRT248820 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT261314 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT443290 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 4 | ||||||||
MIRT443893 | NUDT3 | nudix hydrolase 3 | 2 | 4 | ||||||||
MIRT444057 | SERPINA4 | serpin family A member 4 | 2 | 2 | ||||||||
MIRT444345 | KIAA1211 | KIAA1211 | 2 | 2 | ||||||||
MIRT444538 | AGAP9 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 | 2 | 2 | ||||||||
MIRT444594 | TGFA | transforming growth factor alpha | 2 | 2 | ||||||||
MIRT445601 | SEC14L3 | SEC14 like lipid binding 3 | 2 | 2 | ||||||||
MIRT446025 | PNKD | paroxysmal nonkinesigenic dyskinesia | 2 | 2 | ||||||||
MIRT446309 | TBC1D8B | TBC1 domain family member 8B | 2 | 2 | ||||||||
MIRT446492 | TMEM215 | transmembrane protein 215 | 2 | 4 | ||||||||
MIRT446728 | SLC36A4 | solute carrier family 36 member 4 | 2 | 2 | ||||||||
MIRT447468 | CISD2 | CDGSH iron sulfur domain 2 | 2 | 2 | ||||||||
MIRT447504 | MRPS5 | mitochondrial ribosomal protein S5 | 2 | 2 | ||||||||
MIRT447597 | MRPL3 | mitochondrial ribosomal protein L3 | 2 | 2 | ||||||||
MIRT447636 | AGPS | alkylglycerone phosphate synthase | 2 | 2 | ||||||||
MIRT447846 | ZRANB2 | zinc finger RANBP2-type containing 2 | 2 | 2 | ||||||||
MIRT448098 | TCN2 | transcobalamin 2 | 2 | 2 | ||||||||
MIRT448111 | SEMA4G | semaphorin 4G | 2 | 2 | ||||||||
MIRT448903 | CLCN6 | chloride voltage-gated channel 6 | 2 | 4 | ||||||||
MIRT449396 | TOX4 | TOX high mobility group box family member 4 | 2 | 2 | ||||||||
MIRT449484 | CACNA2D4 | calcium voltage-gated channel auxiliary subunit alpha2delta 4 | 2 | 2 | ||||||||
MIRT450705 | RNF152 | ring finger protein 152 | 2 | 2 | ||||||||
MIRT450781 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT452856 | LAX1 | lymphocyte transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT453048 | TANGO2 | transport and golgi organization 2 homolog | 2 | 2 | ||||||||
MIRT459389 | MPLKIP | M-phase specific PLK1 interacting protein | 2 | 2 | ||||||||
MIRT461156 | SLC11A2 | solute carrier family 11 member 2 | 2 | 4 | ||||||||
MIRT461613 | PTCD3 | pentatricopeptide repeat domain 3 | 2 | 2 | ||||||||
MIRT463711 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 2 | 8 | ||||||||
MIRT464107 | VPS35 | VPS35, retromer complex component | 2 | 2 | ||||||||
MIRT466438 | TFAM | transcription factor A, mitochondrial | 2 | 2 | ||||||||
MIRT467735 | SLC36A1 | solute carrier family 36 member 1 | 2 | 2 | ||||||||
MIRT469512 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 6 | ||||||||
MIRT470026 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT473411 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT480545 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 2 | ||||||||
MIRT488444 | ACBD3 | acyl-CoA binding domain containing 3 | 2 | 2 | ||||||||
MIRT489498 | CRLF3 | cytokine receptor like factor 3 | 2 | 4 | ||||||||
MIRT496149 | RPS15A | ribosomal protein S15a | 2 | 2 | ||||||||
MIRT497013 | PRDM2 | PR/SET domain 2 | 2 | 2 | ||||||||
MIRT497087 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT508695 | MTRNR2L4 | MT-RNR2-like 4 | 2 | 4 | ||||||||
MIRT517468 | PEX26 | peroxisomal biogenesis factor 26 | 2 | 2 | ||||||||
MIRT525329 | CNGB1 | cyclic nucleotide gated channel beta 1 | 2 | 2 | ||||||||
MIRT527842 | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 2 | 2 | ||||||||
MIRT529111 | AQPEP | laeverin | 1 | 1 | ||||||||
MIRT530163 | C11orf44 | chromosome 11 open reading frame 44 | 2 | 4 | ||||||||
MIRT532249 | TBPL2 | TATA-box binding protein like 2 | 2 | 2 | ||||||||
MIRT532828 | ZNF704 | zinc finger protein 704 | 2 | 2 | ||||||||
MIRT533140 | WNT10A | Wnt family member 10A | 2 | 2 | ||||||||
MIRT536481 | KIAA1468 | KIAA1468 | 2 | 2 | ||||||||
MIRT536802 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 2 | ||||||||
MIRT537301 | FRS2 | fibroblast growth factor receptor substrate 2 | 2 | 2 | ||||||||
MIRT542650 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | 2 | 2 | ||||||||
MIRT545691 | NUTF2 | nuclear transport factor 2 | 2 | 2 | ||||||||
MIRT546960 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT560566 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT561792 | PAWR | pro-apoptotic WT1 regulator | 2 | 2 | ||||||||
MIRT562372 | ERI2 | ERI1 exoribonuclease family member 2 | 2 | 2 | ||||||||
MIRT569292 | SURF6 | surfeit 6 | 2 | 2 | ||||||||
MIRT574090 | VASN | vasorin | 2 | 2 | ||||||||
MIRT619787 | HLCS | holocarboxylase synthetase | 2 | 2 | ||||||||
MIRT620104 | HARBI1 | harbinger transposase derived 1 | 2 | 2 | ||||||||
MIRT626003 | ZNF517 | zinc finger protein 517 | 2 | 2 | ||||||||
MIRT626375 | BBS1 | Bardet-Biedl syndrome 1 | 2 | 2 | ||||||||
MIRT626615 | SLC30A6 | solute carrier family 30 member 6 | 2 | 2 | ||||||||
MIRT628381 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT629299 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT630439 | IDE | insulin degrading enzyme | 2 | 2 | ||||||||
MIRT631848 | PIGG | phosphatidylinositol glycan anchor biosynthesis class G | 2 | 2 | ||||||||
MIRT633171 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT633472 | ZNF724P | zinc finger protein 724 | 2 | 2 | ||||||||
MIRT634389 | PLSCR1 | phospholipid scramblase 1 | 2 | 2 | ||||||||
MIRT635536 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT635818 | OPA3 | OPA3, outer mitochondrial membrane lipid metabolism regulator | 2 | 2 | ||||||||
MIRT636165 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT636792 | CYB5D1 | cytochrome b5 domain containing 1 | 2 | 2 | ||||||||
MIRT637946 | IVD | isovaleryl-CoA dehydrogenase | 2 | 2 | ||||||||
MIRT640317 | STAT1 | signal transducer and activator of transcription 1 | 2 | 2 | ||||||||
MIRT645131 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT645658 | ADK | adenosine kinase | 2 | 2 | ||||||||
MIRT646143 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | 2 | 2 | ||||||||
MIRT646999 | NCR3LG1 | natural killer cell cytotoxicity receptor 3 ligand 1 | 2 | 2 | ||||||||
MIRT648183 | C2orf68 | chromosome 2 open reading frame 68 | 2 | 2 | ||||||||
MIRT650085 | TERF2 | telomeric repeat binding factor 2 | 2 | 2 | ||||||||
MIRT650326 | RTN2 | reticulon 2 | 2 | 2 | ||||||||
MIRT651562 | WHSC1L1 | nuclear receptor binding SET domain protein 3 | 2 | 2 | ||||||||
MIRT659367 | CREG2 | cellular repressor of E1A stimulated genes 2 | 2 | 2 | ||||||||
MIRT659830 | CARHSP1 | calcium regulated heat stable protein 1 | 2 | 2 | ||||||||
MIRT662103 | LACTB | lactamase beta | 2 | 4 | ||||||||
MIRT664837 | HUS1 | HUS1 checkpoint clamp component | 2 | 2 | ||||||||
MIRT669750 | ZNF101 | zinc finger protein 101 | 2 | 4 | ||||||||
MIRT669791 | GAN | gigaxonin | 2 | 2 | ||||||||
MIRT670044 | RPP14 | ribonuclease P/MRP subunit p14 | 2 | 2 | ||||||||
MIRT670293 | RBBP4 | RB binding protein 4, chromatin remodeling factor | 2 | 2 | ||||||||
MIRT670382 | EMP2 | epithelial membrane protein 2 | 2 | 2 | ||||||||
MIRT670950 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2 | 4 | ||||||||
MIRT672854 | C22orf29 | retrotransposon Gag like 10 | 2 | 2 | ||||||||
MIRT672885 | FXN | frataxin | 2 | 2 | ||||||||
MIRT673994 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 2 | ||||||||
MIRT674155 | BLOC1S3 | biogenesis of lysosomal organelles complex 1 subunit 3 | 2 | 2 | ||||||||
MIRT674495 | TIRAP | TIR domain containing adaptor protein | 2 | 2 | ||||||||
MIRT675461 | NUBPL | nucleotide binding protein like | 2 | 2 | ||||||||
MIRT675669 | TMOD2 | tropomodulin 2 | 2 | 2 | ||||||||
MIRT675994 | CRKL | CRK like proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT676069 | TIMM50 | translocase of inner mitochondrial membrane 50 | 2 | 2 | ||||||||
MIRT676378 | SEC24D | SEC24 homolog D, COPII coat complex component | 2 | 2 | ||||||||
MIRT676759 | SNX2 | sorting nexin 2 | 2 | 2 | ||||||||
MIRT676893 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT676973 | ZNF708 | zinc finger protein 708 | 2 | 2 | ||||||||
MIRT677229 | C15orf40 | chromosome 15 open reading frame 40 | 2 | 2 | ||||||||
MIRT677363 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT677456 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT678073 | EIF2A | eukaryotic translation initiation factor 2A | 2 | 2 | ||||||||
MIRT678091 | ATCAY | ATCAY, caytaxin | 2 | 2 | ||||||||
MIRT678316 | FBLIM1 | filamin binding LIM protein 1 | 2 | 2 | ||||||||
MIRT678411 | ANKRD36 | ankyrin repeat domain 36 | 2 | 2 | ||||||||
MIRT678519 | ZNF347 | zinc finger protein 347 | 2 | 2 | ||||||||
MIRT678695 | TRIP11 | thyroid hormone receptor interactor 11 | 2 | 2 | ||||||||
MIRT678821 | PDE6A | phosphodiesterase 6A | 2 | 2 | ||||||||
MIRT679984 | RUNDC1 | RUN domain containing 1 | 2 | 2 | ||||||||
MIRT680608 | KIAA0391 | KIAA0391 | 2 | 2 | ||||||||
MIRT680724 | PRICKLE1 | prickle planar cell polarity protein 1 | 2 | 2 | ||||||||
MIRT681238 | ZNF383 | zinc finger protein 383 | 2 | 2 | ||||||||
MIRT681932 | SLC19A3 | solute carrier family 19 member 3 | 2 | 2 | ||||||||
MIRT682003 | ATP5S | ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B) | 2 | 2 | ||||||||
MIRT682500 | HERPUD1 | homocysteine inducible ER protein with ubiquitin like domain 1 | 2 | 2 | ||||||||
MIRT685460 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT688193 | FNIP1 | folliculin interacting protein 1 | 2 | 2 | ||||||||
MIRT689666 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT691058 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT691442 | CXorf36 | chromosome X open reading frame 36 | 2 | 2 | ||||||||
MIRT695998 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT696395 | CORO7 | coronin 7 | 2 | 2 | ||||||||
MIRT702334 | KLHL7 | kelch like family member 7 | 2 | 2 | ||||||||
MIRT702555 | KBTBD6 | kelch repeat and BTB domain containing 6 | 2 | 2 | ||||||||
MIRT703362 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | 2 | 2 | ||||||||
MIRT703551 | FKBP14 | FK506 binding protein 14 | 2 | 2 | ||||||||
MIRT705029 | CACUL1 | CDK2 associated cullin domain 1 | 2 | 2 | ||||||||
MIRT706335 | STAC2 | SH3 and cysteine rich domain 2 | 2 | 2 | ||||||||
MIRT708907 | TM4SF19 | transmembrane 4 L six family member 19 | 2 | 2 | ||||||||
MIRT711625 | CORO1C | coronin 1C | 2 | 2 | ||||||||
MIRT714444 | TOPAZ1 | testis and ovary specific PAZ domain containing 1 | 2 | 2 | ||||||||
MIRT716324 | POU5F1 | POU class 5 homeobox 1 | 2 | 2 | ||||||||
MIRT718568 | SLC25A22 | solute carrier family 25 member 22 | 2 | 2 | ||||||||
MIRT720299 | DDHD1 | DDHD domain containing 1 | 2 | 2 | ||||||||
MIRT721449 | AGPAT6 | glycerol-3-phosphate acyltransferase 4 | 2 | 2 | ||||||||
MIRT723529 | NFATC2IP | nuclear factor of activated T-cells 2 interacting protein | 2 | 2 | ||||||||
MIRT724492 | BFAR | bifunctional apoptosis regulator | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|